FDG PET/CT scan after unexplained stroke to find hidden cancer
Part of Brain & nervous system, Heart & circulation clinical trials.
This study checks whether doing an intensive scan using FDG PET/CT shortly after a “cryptogenic” (unexplained) ischemic stroke can uncover an underlying cause, such as cancer. If a hidden source is found earlier, it may help guide the next treatment steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- You had your first ischemic stroke that was not explained after advanced work-up.
- The stroke happened within the last 3 months.
- You can give informed consent (or a trusted delegate can help).
- You can safely have an FDG PET/CT scan (for example, you are not pregnant and can lie still for about 20 minutes).
- You have not had active cancer before (except skin basal or squamous cell cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for hidden cancers in people who have had a stroke and have high levels of a blood marker called D-dimer. It aims to see if a full cancer screening one year later can find new cancers that might have been missed.
This study uses a special brain scan (PET) to learn more about how artery hardening (atherosclerosis) affects stroke. It is for people who have just had a stroke and may help doctors understand the disease better.
This study looks at how blood clots form and contribute to an acute ischemic (clot-related) stroke. It uses PET-CT scanning to better understand the process and may help improve how future stroke treatments are targeted.
This study uses a special brain scan (PET-CT) to help find where a stroke might have come from. It could help doctors better understand and treat strokes.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This study tests a special PET scan that may help find where a cancer that started somewhere unknown originated. It could help doctors choose the right treatment by locating the hidden primary tumor.
Hear when a new Occult Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.